SCHEMBL28159355

SCHEMBL28159355

OCC1CCCc2ccc3c(ccc4ccccc43)c21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 1/20 0.42
ADRA2B P18089 1/20 0.42
ADRA2C P18825 1/20 0.42
HPRT1 P00492 1/20 0.40
CYP1A2 P05177 2/20 0.38
CYP2D6 P10635 2/20 0.38
CYP2C9 P11712 2/20 0.38
CYP2C19 P33261 2/20 0.38
HIF1A Q16665 2/20 0.38
ALDH1A1 P00352 4/20 0.34
HSD17B10 Q99714 2/20 0.34
CYP2A6 P11509 1/20 0.34
TSHR P16473 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
KDM4E B2RXH2 3/20 0.33
CDK4 P11802 2/20 0.33
CCND1 P24385 2/20 0.33
GAA P10253 2/20 0.33
HPGD P15428 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28123487 0.90 ADRA2A (0.41) ADRA2AADRA2BADRA2CHPRT1CYP1A2
SCHEMBL28126370 0.86 ADRA2A (0.42) ADRA2AADRA2BADRA2CHPRT1CYP1A2
SCHEMBL27865360 0.86 ADRA2A (0.45) ADRA2AADRA2BADRA2CHPRT1CYP1A2
SCHEMBL27786102 0.86 ADRA2A (0.42) ADRA2AADRA2BADRA2CHPRT1CYP1A2
SCHEMBL28197359 0.86 ADRA2A (0.42) ADRA2AADRA2BADRA2CHPRT1CYP1A2
SCHEMBL28133212 0.86 ADRA2A (0.42) ADRA2AADRA2BADRA2CHPRT1CYP1A2
SCHEMBL27805312 0.84 ADRA2A (0.41) ADRA2AADRA2BADRA2CHPRT1CYP1A2
SCHEMBL28148564 0.83 ADRA2A (0.41) ADRA2AADRA2BADRA2CHPRT1CYP1A2
SCHEMBL28140151 0.83 ADRA2A (0.41) ADRA2AADRA2BADRA2CHPRT1CYP1A2
SCHEMBL28129370 0.83 CYP1A2 (0.39) ADRA2AADRA2BADRA2CHPRT1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106008322-B sulfonamide derivatives as BC L-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases ABBVIE 公司 2018-09-04 CN disclosed
CN-107531728-A Amino hydrogen thiazine derivative available for the tetrahydrofuran fusion for the treatment of Alzheimer's 伊莱利利公司 2018-01-02 CN disclosed
CN-107278203-A It is used as pyrazolo [1,5 a] pyrazine of 4,6 substitutions of JANUS kinase inhibitors 阵列生物制药公司 2017-10-20 CN disclosed
CN-107001281-A Substituted benzothiophene radical derivative is used as the GPR40 activators for treating type ii diabetes 詹森药业有限公司 2017-08-01 CN disclosed
CN-102307872-B BCL-2-selectively apoptosis-inducing agents for the treatment of cancer and immune diseases ABBVIE 公司 2016-06-15 CN disclosed